Zentalis Pharmaceuticals, Inc. (ZNTL) Tops Q2 EPS by 17c

Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) reported Q2 EPS of ($0.37), $0.17 better than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Zentalis Pharmaceuticals, Inc. (ZNTL) click here.

You May Also Be Interested In

• Dell Technologies (DELL) Tops Q2 EPS by $2.17, Offers Guidance
• Raymond James Starts Arrow Financial Corporation (AROW) at Outperform
• Edison Int'l (EIX) call put ratio 2.1 calls to 1 put as share price up 8.6%